The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Iakupov É.Z.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki Kazanskogo gosudarstvennogo meditsinskogo universiteta

Adjuvant therapy of pain syndromes: possibilities of using nucleotides

Authors:

Iakupov É.Z.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10): 141‑145

DOI: 10.17116/jnevro2019119101141

Read: 7185 times

Download PDF (RU)
Contact the author
Table of contents

ADJUVANT THERAPY OF PAIN SYNDROMES: POSSIBILITIES OF USING NUCLEOTIDES
ADJUVANT THERAPY OF PAIN SYNDROMES: POSSIBILITIES OF USING NUCLEOTIDES

To cite this article:

Iakupov ÉZ. Adjuvant therapy of pain syndromes: possibilities of using nucleotides. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10):141‑145. (In Russ.)
https://doi.org/10.17116/jnevro2019119101141

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Despite the variety of treatment options, pain syndromes are widespread in the population. Adjuvant methods, in particular vitamins and vitamin combinations, are widely used, along with nonsteroidal anti-inflammatory drugs, myorelaxants and anticonvulsants, by physicians of different specialties. In recent years, new drugs containing pyrimidine nucleotides (uridine monophosphate) were brought to market. The paper describes analgesic effects of uridine monophosphate and choline, possibilities of their simultaneous use in combination with vitamins to promote the recovery of damaged structured of the peripheral nervous system, including remyelination and neuroplasticity. It has been concluded that nucleotide complexes can be effectively used as adjuvant therapy of pain.

Keywords:

pain syndromes
pain stopping
nucleotides
uridine monophosphate
choline

Authors:

Iakupov É.Z.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki Kazanskogo gosudarstvennogo meditsinskogo universiteta

Close metadata

References:

  1. Disease and Injury Incidence and Prevalence Collaborators. Global, regional,and national incidence, prevalence, and years lived with disability for 310 diseases andinjuries, 1990—2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;356:1545-602. https://doi.org/10.1016/S0140-6736(16)31678-6 pmid:27733282
  2. Walker BF. The prevalence of low back pain:a systematic review of the literature from 1966 to 1998. J Spinal Disord. 2000;13:205-217. https://doi.org/10.1097/00002517-200006000-00003
  3. Martin BI. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656-664. https://doi.org/10.1001/jama.299.6.656
  4. Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci. 1994;122(2):140-143. https://doi.org/10.1016/0022-510x(94)90290-9
  5. Fonseca VA, Lavery LA, Thethi TK. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med. 2013;126(2):141-149. https://doi.org/10.1016/j.amjmed.2012.06.022
  6. Trippe BS, Barrentine LW, Curole MV, Tipa E. Nutritional management of patients with diabetic peripheral neuropathy with Metanx: results of a real-world patient experience trial. Curr Med Res Opin. 2016;32(2):219-227. https://doi.org/10.1185/03007995.2015.1103215
  7. obezbolivaniya. Rossijskij zhurnal boli. 2019;17(1):51-56. (In Russ.) https://doi.org/10.25731/RASP.2019.01.09
  8. Ford AP. In pursuit of P2X3 antagonists: Novel therapeutics for chronic pain and afferent sensitization. Purinergic Signalling. 2012;8:3-26. https://doi.org/10.1007/s11302-011-9271-6
  9. Nair A, Simonetti M, Birsa N, Ferrari M D, van den Maagdenberg AM, Giniatullin R, Nistri A, Fabbretti E. Familial hemiplegic migraine Cav2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain. Molecular Pain. 20106;48. https://doi.org/10.1186/1744-8069-6-48
  10. Inoue K, Tsuda M, Tozaki-Saitoh H. Modification of neuropathic pain sensation through microglial ATP receptor. Purinergic Sig. 2007;3:311-316. https://doi.org/10.1007/s11302-007-9071-1
  11. Goldberg H, Mibielli MA, Nunes CP, Goldberg SW, Buchman L, Mezitis SGE, Rzetelna H, Oliveira L, Geller M, Wajnsztajn F. A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias. J Pain Res. 2017;10:397-404. https://doi.org/10.2147/JPR.S123045
  12. Gallai V, Mazzotta G, Montesi S. Sarchielli P, GattoF. Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study. Acta Neurol Scand. 1992;86(1):3-7. https://doi.org/10.1111/j.1600-0404.1992.tb08045.x
  13. Palomo-Guerrero M, Cosgaya JM, Gella A, Casals N, Grijota-Martinez C. Uridine-5’-triphosphate partially blocks differentiation signals and favors a more repair state in cultured rat Schwann cells. Neuroscience. 2018;372:255-265. https://doi.org/10.1016/j.neuroscience.2018.01.010
  14. Lamarca A, Gella A, Martiañez T, Segura M, Figueiro-Silva J, Grijota-Martinez C, Trullas R, Casals N. Uridine-5-triphosphate promotes in vitro schwannoma cell migration through matrix metalloproteinase-2 activation. PLoS One. 2014;9(6):e98998. https://doi.org/10.1371/journal.pone.0098998
  15. Negrão L, Almeida P, Alcino S, Duro H, Libório T, Silva UM, Figueira R, Gonçalves S, Parra LN. Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Manag. 2014;4(3):191-196. https://doi.org/10.2217/pmt.14.10
  16. Gareri P, Castagna A, Cotroneo AM. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-1429. https://doi.org/10.2147/CIA.S87886
  17. Arenth PM, Russell KC, Ricker JH, Zafonte RD. CDP-choline as a biological supplement during neurorecovery: a focused review. PMR. 2011;3(6 suppl 1):123-131. https://doi.org/10.1016/j.pmrj.2011.03.012
  18. Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol. 2016;63(3):1-73.
  19. Kanat O, Bagdas D, Ozboluk HY, Gurun MS. Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain. J BUON. 2013;18(4):1012-1018.
  20. Özay R, Bekar A, Kocaeli H, Karlı N, Filiz G, UlusIH.Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats. Surg Neurol. 2007;68(6):615-622. https://doi.org/10.1016/j.surneu.2006.12.054
  21. Arenth PM, Russell KC, Ricker JH, Zafonte RD. CDP-choline as a biological supplement during neurorecovery: a focused review. PMR. 2011;3(6 suppl 1):123-131. https://doi.org/10.1016/j.pmrj.2011.03.012
  22. Rowley TJ, McKinstry A, Greenidge E, Smith W. Flood P. Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain. British Journal of Anaesthesia. 2010;105(2):201-207. https://doi.org/10.1093/bja/aeq113
  23. Sidhu N, Davies S, Nadarajah A, Rivera J, Whittington R, Mercier RJ, Virag L, Wang S, Flood P. Oral choline supplementation for postoperative pain. British Jornal of Anestesia. 2013;111(2):249-255. https://doi.org/10.1093/bja/aet031
  24. Ahlawat A, Sharma S. A new promising simultaneous approach for attenuating type II diabetes mellitus induced neuropathic pain in rats: iNOS inhibition and neuroregeneration. Eur J Pharmacol. 2018;818:419-428. https://doi.org/10.1016/j.ejphar.2017.11.010
  25. Caner B, Kafa MI, Bekar A, Kurt MA, Karli N, Cansev M, Ulus IH. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Neurol Res. 2012;34(3):238-245. https://doi.org/10.1179/1743132812Y.0000000003
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.